GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ocumetics Technology Corp (TSXV:OTC) » Definitions » EBITDA Margin %

Ocumetics Technology (TSXV:OTC) EBITDA Margin % : 0.00% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ocumetics Technology EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Ocumetics Technology's EBITDA for the three months ended in Mar. 2024 was C$-0.59 Mil. Ocumetics Technology's Revenue for the three months ended in Mar. 2024 was C$0.00 Mil. Therefore, Ocumetics Technology's EBITDA margin for the quarter that ended in Mar. 2024 was 0.00%.


Ocumetics Technology EBITDA Margin % Historical Data

The historical data trend for Ocumetics Technology's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocumetics Technology EBITDA Margin % Chart

Ocumetics Technology Annual Data
Trend Jul20 Jul21 Dec22 Dec23
EBITDA Margin %
- - - -

Ocumetics Technology Quarterly Data
Jul20 Jul21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Ocumetics Technology's EBITDA Margin %

For the Medical Instruments & Supplies subindustry, Ocumetics Technology's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ocumetics Technology's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ocumetics Technology's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Ocumetics Technology's EBITDA Margin % falls into.



Ocumetics Technology EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Ocumetics Technology's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-3.497/0
= %

Ocumetics Technology's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-0.591/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ocumetics Technology  (TSXV:OTC) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Ocumetics Technology EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Ocumetics Technology's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ocumetics Technology (TSXV:OTC) Business Description

Traded in Other Exchanges
Address
639 - 5th Avenue S.W., Suite 1250, Calgary, AB, CAN, T2P 0M9
Ocumetics Technology Corp is a Canadian-based research and product development company. The company is engaged in developing an accommodating intraocular lens to eliminate the need for corrective lenses, especially for people over 45 years of age.
Executives
Roger Jewett Director, Senior Officer

Ocumetics Technology (TSXV:OTC) Headlines

No Headlines